Literature DB >> 3485757

Modification of cellular immune functions in humans by endurance exercise training during beta-adrenergic blockade with atenolol or propranolol.

R R Watson, S Moriguchi, J C Jackson, L Werner, J H Wilmore, B J Freund.   

Abstract

Young, healthy, previously inactive men were trained aerobically 40 to 50 min X d-1, 5 d X wk-1 for 15 wk. They were randomly assigned to one of three medication groups: placebo, propranolol (160 mg X d-1), or atenolol (100 mg X d-1). All subjects lost weight and decreased relative body fat as a result of training. Following training, submaximal steady-state heart rates were reduced in all groups. Maximal oxygen uptake and maximal treadmill times were also increased in all groups. The VO2max of the placebo increased 18.4%. While that of the atenolol group increased 19.4%, the propranolol group went up 17.0%. After training the maximal heart rate did not change in the placebo group, while treatment with propranolol and atenolol reduced at 24.6 and 21.9%, respectively. Training caused a significant decrease in the natural killer cell activity in all three groups. The placebo group had 38.8% +/- 3.8 (SD) before and 29.3 +/- 3.2% lysis of target cells by natural killer cells after physical conditioning, which was significantly lower (P less than 0.01). The groups treated with propranolol and atenolol were also similarly decreased. The use of propranolol or atenolol had no additional significant effect on natural killer cell activity. T-cell mitogenesis stimulated with a mitogen significantly increased with conditioning. The groups given atenolol or propranolol tended to increase somewhat more than the placebo group, although this difference was not statistically significant. There was no significant change in the percentage of total lymphocytes isolated due to training or beta-blockade.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485757

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  15 in total

1.  Effects of exercise and training on natural killer cell counts and cytolytic activity: a meta-analysis.

Authors:  R J Shephard; P N Shek
Journal:  Sports Med       Date:  1999-09       Impact factor: 11.136

2.  Potential markers of heavy training in highly trained distance runners.

Authors:  T Verde; S Thomas; R J Shephard
Journal:  Br J Sports Med       Date:  1992-09       Impact factor: 13.800

3.  Exercise intervention attenuates emotional distress and natural killer cell decrements following notification of positive serologic status for HIV-1.

Authors:  A R LaPerriere; M H Antoni; N Schneiderman; G Ironson; N Klimas; P Caralis; M A Fletcher
Journal:  Biofeedback Self Regul       Date:  1990-09

Review 4.  Exercise and natural killer cells. What is the relationship?

Authors:  L T Mackinnon
Journal:  Sports Med       Date:  1989-03       Impact factor: 11.136

Review 5.  Overtraining in athletes. An update.

Authors:  R W Fry; A R Morton; D Keast
Journal:  Sports Med       Date:  1991-07       Impact factor: 11.136

6.  Changes in blood leucocyte populations induced by acute maximal and chronic submaximal exercise.

Authors:  A Ferry; F Picard; A Duvallet; B Weill; M Rieu
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1990

Review 7.  Potential therapeutics of vitamin E (tocopherol) in AIDS and HIV.

Authors:  Y Wang; R R Watson
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

8.  The effects of incremental submaximal exercise on circulating leukocytes in physically active and sedentary males and females.

Authors:  N M Moyna; G R Acker; K M Weber; J R Fulton; F L Goss; R J Robertson; B S Rabin
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

9.  Reduction of saliva immunoglobulin levels by swim training.

Authors:  G D Tharp; M W Barnes
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1990

Review 10.  Exercise and the immune system. Natural killer cells, interleukins and related responses.

Authors:  R J Shephard; S Rhind; P N Shek
Journal:  Sports Med       Date:  1994-11       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.